Synkrino Biotherapeutics Company
Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients.
Technology:
Data-driven Technologies
Industry:
Artificial Intelligence, Biotechnology, Early Drug Development, Health Care, PharmTech, Therapeutics, United States
Headquarters:
Berkeley, California, United States
Founded Date:
2018-01-01
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
2
Estimated Revenue:
Less than $1M
Last Funding Date:
2018-08-23
Last Funding Type:
Seed
Register and Claim Ownership